China Biologic To Attend Upcoming Investor Conferences
BEIJING, Sept. 10, 2015 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company will participate in the following investor conferences in September 2015:
On September 10-11, 2015, China Biologic will participate in the Deutsche Bank 14th Annual Global Emerging Markets One-on-One Conference at The Waldorf Astoria in New York.
On September 15, 2015, China Biologic will participate in the 2015 Morgan Stanley Asia Pacific Healthcare Day at the Boston Harbor Hotel in Boston.
On September 16-17, 2015, China Biologic will participate in the 2015 Morgan Stanley Global Healthcare Conference at the Grand Hyatt New York in New York.
Mr. David Gao, Chairman and Chief Executive Officer, Mr. Ming Yang, Chief Financial Officer, and Mr. Ming Yin, Senior Vice President of China Biologic, will present and meet with investors at these events. For additional information or interest in meeting with management, please contact the institutional sales representative at each respective bank.
About China Biologic Products, Inc.
China Biologic is a leading plasma-based biopharmaceutical company in China. The Company's products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and manufactures over 20 different dosages of plasma-based products through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guizhou Taibang Biological Products Co., Ltd. The Company also has an equity investment in Xi'an Huitian Blood Products Co., Ltd. The Company sells its products to hospitals and inoculation centers, as well as distributors, in China. For additional information, please see the Company's website, www.chinabiologic.com.
Contact:
China Biologic Products, Inc.
Mr. Ming Yin
Senior Vice President
Phone: +86-10-6598-3099
Email: ir@chinabiologic.com
ICR Inc.
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
E-mail: bill.zima@icrinc.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/china-biologic-to-attend-upcoming-investor-conferences-300140674.html
SOURCE China Biologic Products, Inc.
Help employers find you! Check out all the jobs and post your resume.